VAG
ZVRA icon

VisionPoint Advisory Group’s Zevra Therapeutics ZVRA Stock Holding History

VisionPoint Advisory Group’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,730
Closed -$8.48K – 814
2024
Q2 		$8.48K Buy
1,730
+530
+44% +$2.51K ﹤0.01% 507
2024
Q1 		$6.96K Sell
1,200
-5,660
-83% -$34.8K ﹤0.01% 499
2023
Q4 		$44.9K Hold
6,860
– – 0.02% 250
2023
Q3 		$33.1K Sell
6,860
-2,182
-24% -$10.9K 0.01% 290
2023
Q2 		$46.1K Sell
9,042
-1,175
-12% -$6.33K 0.02% 217
2023
Q1 		$49.9K Hold
10,217
– – 0.02% 141
2022
Q4 		$54.6K Hold
10,217
– – 0.02% 133
2022
Q3 		$64K Hold
10,217
– – 0.03% 95
2022
Q2 		$63K Buy
+10,217
New +$46.6K 0.02% 99

Other funds holding ZVRA

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JGC
J. Goldman & Co New York $2.16B AUM 33.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return